Intravitreal bevacizumab for posterior capsule neovascularization.

Autor: Al-Mohaimeed M; College of Medicine, Al-Qassim University, Al-Qassim, P.O. Box 6655, Buraidah 51452, Saudi Arabia., Al-Gehedan S, Dhibi HA
Jazyk: angličtina
Zdroj: Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society [Saudi J Ophthalmol] 2010 Apr; Vol. 24 (2), pp. 63-5. Date of Electronic Publication: 2010 Apr 02.
DOI: 10.1016/j.sjopt.2010.02.002
Abstrakt: We report a case of rapid regression of extensive posterior capsule neovascularization in a 67-year-old diabetic male patient, who developed posterior capsule opacity with neovascularization one year post cataract surgery, after a single injection of intravitreal bevacizumab (Avastin) followed by neodymium:YAG capsulotomy. Rapid regression of the posterior capsule neovascularization, and visual improvement was observed 9 days after the intervention. Posterior capsulotomy was performed successfully without bleeding. Prior to posterior capsulotomy, intravitreal bevacizumab can result in rapid and dramatic regression of posterior capsule neovascularization.
Databáze: MEDLINE